Category: General
Q1 2025 sales update
Financial results for the first nine months of 2024
Financial results for the first half of 2024
Our 2023 Integrated Annual Report is live!
A year of innovation and impact In 2023, we entered the next phase of our journey of growth and innovation,
Q1 2024 sales update
Applications now open for the 2024 Golden Ticket competition
As part of our commitment to accelerating transformative research and development, we’re excited to announce that our annual Golden Ticket
FY 2023 results announcement
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
Starting now and throughout 2024, Ipsen is sponsoring five talented, elite athletes on their journeys toward the 2024 Paralympic Games.
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has commissioned Dolon to develop a report to assess the impact